Heidelberg, Germany, July 16, 2024 – Heidelberg Epignostix, a deeptech start-up committed to precision cancer diagnostics today announces the appointment of Helge Lubenow as CEO. She will be succeeding founder David Jones in the role who will continue to support Heidelberg Epignostix as Chief Scientific Officer. Helge Lubenow has almost 25 years of industry experience and held senior positions in the life sciences and diagnostics industry. She began her career at QIAGEN where she ultimately served as Head of the Diagnostics Business.
“We are very excited for Helge to support us in the next phase of our development” said David Jones, “as we are committed to creating a transformative portfolio of cancer diagnostic tools in brain tumors and beyond.” Felix Sahm, co-founder and Head of Molecular Neuropathology at the Heidelberg University Hospital adds: “There is a high unmet need in personalized patient management that calls for the rapid development of a clinically certified tool, to enable routine use and broad adoption for improved patient outcomes.”
“I feel very honored being able to join such a world-class team and am deeply impressed about the achievements that have been made already. I am committed to improving cancer care and quality of life outcomes for the benefit of patients and their families, community and ultimately society” said Helge Lubenow
About Heidelberg Epignostix GmbH:
Heidelberg Epignostix is a healthcare company whose mission is to transform cancer diagnostics through data science. The company has developed novel AI-based bioinformatics algorithms with utility in cancer classification for improved accuracy in cancer diagnosis, prognosis and therapy management. The lead product, the Heidelberg Brain Tumor Classifier, is currently available as a research-use-only resource. Heidelberg Epignostix is located in Heidelberg, Germany. For more information visit www.epignostix.com.
For further inquiries:
Areeba Patel, Head of New Technologies
Heidelberg Epignostix GmbH
Köpfelweg 58
69118 Heidelberg
Germany
Email: areeba.patel@epignostix.com
www.epignostix.com
